Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis
Aude Mignot(Université de Poitiers), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Myriam Pujo(Centre Hospitalier d'Angoulême), A Delcourt(Sorbonne Université), Shaïda Varnous(Université Paris-Est Créteil), Frank Bridoux(Université de Poitiers), Antoine Thierry(Université de Poitiers), Jean Michel Goujon(Université de Poitiers), J. Gombert(Université de Poitiers), D Herpin(Centre Jean Bernard), Frédéric Favreau(Université de Poitiers)
Cited by 17
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809